Scope Biosciences raised €1.0M in a funding round in Nov 2021. The company is based in Wageningen, Netherlands. Investors in the round: GenDx. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €1.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
